Telix Pharmaceuticals Health Care
Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom

$11.22 -0.22 (-1.92%)

High $11.49	Low $11.20	Trades 4,718	Turnover $7,499,551	Volume 664,557
30 June 2023 at 4:12pm

Market Cap (26-Oct) $4,481,754,624 (204th)	Close (30-Jun) $11.22 -0.22 (-1.92%)	Volume (30-Jun) 664,557	Shortsold (19-Oct) 36,725,267 (10.79%) (11th)
52w High $18.22	52w Low $8.26	P/E 250.00	EPS 0.15

[ARTICLE] Telix shares hit new high on upgraded revenue forecast

MediaBot

July 18, 2024 23:47

A news article has been posted about Telix Pharmaceuticals on the AFR. The article was published around July 18, 2024 23:47, on 18 July 2024 at 11:47pm.

Cancer diagnostics specialist Telix Pharmaceuticals has upgraded its full-year revenue forecast following a strong second quarter, sending the market darling’s shares to a fresh record high. Telix shares, which have doubled in value since the start of ...

Read Article

TLX was $11.22 at the close of trade on 30 June 2023

Recent Articles about ASX:TLX
14-Sep	FDA Approves Telix's Brain Cancer Imaging Drug Pixclara - AFR company-announcements.afr.com
13-Sep	Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with ... company-announcements.afr.com
13-Sep	Telix Appoints David Gill as Chair - ASX Announcement - Market Index company-announcements.afr.com
21-Jul	Notice of change of interests of substantial holder - AFR company-announcements.afr.com
21-Jul	Q2 Business Update - Telix Pharmaceuticals Limited company-announcements.afr.com
19-Jul	Appendix 3H - Notification of cessation of securities - AFR company-announcements.afr.com
17-Jul	Appendix 3G - Notification of issue, conversion or payment up ... - AFR company-announcements.afr.com
4-Jul	Q1 2026 Strong Revenue Growth and Tx Pipeline Advancement company-announcements.afr.com
3-Jul	604 Page 1 of 6 - Market Index company-announcements.afr.com
3-Jul	Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain ... company-announcements.afr.com
Tracked

Find all articles about Telix Pharmaceuticals, including others on the AFR, on the media page.

You must login or register to post a comment.

You must be logged in to post a reply.

End of Day Prices

Date	Close	Volume	Change
23-Oct	$13.19	3,151,131	-0.47 (3.44%)
22-Oct	$13.66	4,272,393	-0.86 (5.92%)
21-Oct	$14.52	4,382,368	-1.24 (7.87%)
20-Oct	$15.76	1,197,406	+0.36 (2.34%)
19-Oct	$15.40	1,107,461	-0.33 (2.10%)
16-Oct	$15.73	1,326,481	+0.65 (4.31%)
15-Oct	$15.08	1,815,274	-0.26 (1.69%)
14-Oct	$15.34	1,104,996	-0.44 (2.79%)
13-Oct	$15.78	1,317,037	-0.52 (3.19%)
12-Oct	$16.30	1,208,628	+0.45 (2.84%)
09-Oct	$15.85	1,026,543	0.00 (0.00%)
08-Oct	$15.85	1,297,945	-0.02 (0.13%)
07-Oct	$15.87	2,364,422	+0.46 (2.99%)
06-Oct	$15.41	1,114,504	-0.14 (0.90%)
05-Oct	$15.55	1,268,082	+0.39 (2.57%)
5 up, 9 down, and 1 flat days

Telix Pharmaceuticals Health Care
Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom

[ARTICLE] Telix shares hit new high on upgraded revenue forecast

MediaBot

Followers

Prices

Announcements

End of Day Prices

Telix Pharmaceuticals Health Care Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom

[ARTICLE] Telix shares hit new high on upgraded revenue forecast

MediaBot

Followers

Prices

Announcements

End of Day Prices

Telix Pharmaceuticals Health Care
Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom